Edition:
United States

CareDx Inc (CDNA.OQ)

CDNA.OQ on NASDAQ Stock Exchange Global Market

7.12USD
13 Dec 2017
Change (% chg)

$0.03 (+0.42%)
Prev Close
$7.09
Open
$7.10
Day's High
$7.29
Day's Low
$7.05
Volume
32,190
Avg. Vol
121,292
52-wk High
$7.98
52-wk Low
$0.76

Chart for

About

CareDx, Inc. is a molecular diagnostics company. The Company is focused on the discovery, development and commercialization of clinically differentiated diagnostic surveillance solutions for transplant patients. The Company's commercialized testing solution, the AlloMap heart transplant molecular test (AlloMap), is a gene... (more)

Overall

Beta: 1.00
Market Cap(Mil.): $203.60
Shares Outstanding(Mil.): 28.60
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 188.50 15.25
EPS (TTM): -- -- --
ROI: -- -11.67 33.27
ROE: -- -36.21 16.35

BRIEF-Caredx reports third quarter loss of $0.63 per share

* Sees fy 2017 revenue $47 million to $49 million Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

Nov 09 2017

BRIEF-Biocardia announces reverse stock split and release of indemnity holdback shares

* Biocardia announces reverse stock split and release of indemnity holdback shares

Nov 02 2017

BRIEF-CareDx closes public offering of common stock

* CareDx announces closing of public offering of common stock Source text for Eikon: Further company coverage:

Oct 10 2017

BRIEF-Caredx entered into an underwriting agreement with Craig-Hallum Capital Group - SEC filing

* Caredx Inc - on October 4, co entered into an underwriting agreement with Craig-Hallum capital Group LLC - SEC filing

Oct 05 2017

BRIEF-CareDx says currently offering of up to 3.6 mln shares versus previously expected offering of up to 3 mln shares

* CareDx Inc says currently offering of up to 3.6 million shares of common stock versus previously expected offering of up to 3.0 million shares of common stock‍​ Source: (http://bit.ly/2xTuyf5) Further company coverage:

Oct 02 2017

BRIEF-CareDx files for offering of 3 million shares of its common stock - SEC filing

* Files for offering of 3 million shares of its common stock - SEC filing Source text: [http://bit.ly/2iOXsaP] Further company coverage:

Sep 01 2017

BRIEF-CareDx Inc files prospectus related to resale of 2.8 million shares of common stock by selling stockholders‍​

* CareDx Inc files prospectus related to resale of 2.8 million shares of common stock by selling stockholders - SEC filing‍​ Source text : (http://bit.ly/2vwR9JY) Further company coverage:

Aug 25 2017

BRIEF-CareDx reports Q2 loss per share $0.19

* Q2 earnings per share view $-0.19 -- Thomson Reuters I/B/E/S

Aug 10 2017

Competitors

Earnings vs. Estimates